AstraZeneca’s Tagrisso with chemo approved in China as 1st-line treatment EP News Bureau Jun 26, 2024 Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy reduced the risk of disease progression or death by…
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029:… EP News Bureau Oct 11, 2023 GlobalData reveals that a total of 39 small molecules have been commercialised for the treatment of lung cancer, with a total of…
AstraZeneca Pharma India files writ petition in Delhi High Court against NPPA demand notice Press Trust of India Jun 30, 2021 The notice of demand alleges that the company has overcharged about Rs 157.38 crore from March 8, 2019 to January 31, 2021, for…
AstraZeneca’s Tagrisso helps lung cancer patients live longer: study Reuters Aug 9, 2019 The British drugmaker announced overall positive survival results from the study in patients with epidermal growth factor…